Australia's most trusted
source of pharma news
Wednesday, 15 January 2025
Posted 5 September 2024 PM
The Federal Government is under mounting pressure to ban the use of genetic test results by life insurance companies with the Australian Academy of Health and Medical Sciences (AAHMS) the latest to join supporters, which includes AstraZeneca.
The government is currently considering its response to consultation on the topic, following a Monash report called A-GLIMMER which found ongoing discrimination is taking place, deterring Aussies from undergoing testing.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.